Roche Holding AG RHHBF OTC

Roche Holding AG (RHHBF) has shown declining revenue growth over the past 3 years, expanding from $63.3B to $61.5B (average -0.9%/yr). Net income reached $12.9B, reflecting solid earnings growth at +6.7%/yr on average. The net profit margin is 20.9%, which is high. The company has maintained profitability in all 4 of the past 4 years, demonstrating a consistent earnings track record. The gross margin is 72.9% (high), with a +5.1pp trend over the period. With a $333B market cap and MOAT composite score of 94/100, the company has a strong competitive position.

Criteria proven by this page:

• GROWTH (40/100, Partial) — growth is present but not consistently above 5% across both metrics
• PAST (100/100, Pass) — proving consistent earnings. Looking at the full 28-year history, the company was profitable in 27 of 28 years — an excellent long-term track record
• INCOME (85/100, Pass) — proves strong profitability and pricing power
• MOAT (94/100, Pass) — strong gross margins and market scale prove a durable competitive advantage

Overall SharesGrow Score: 67/100 with 4/7 criteria passed.